PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden. nina.lagerqvist@folkhalsomyndigheten.se.\', \'Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.\', \'Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Clinical Microbiology, Umeå University, Umeå, Sweden.\', \'Region Västmanland, Västerås, Sweden.\', \'Karolinska University Hospital, Stockholm, Sweden.\', \'Region Västernorrland, County Hospital of Västernorrland, Sundsvall, Sweden.\', \'Region Värmland, Centralsjukhuset, Karlstad, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-87289-6
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33828214
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all